Actual Medicinal Product (AMP) Zopiclone 3.75mg tablets (Medihealth (Northern) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light and moisture. Anecdotal reports of use in MCAs (low quality evidence). Manufacturer recommends storing in original container.
- Provenance
-
This recommendation is based on the products Zimovane LS 3.75mg tablets and Zopiclone 3.75mg film coated tablets (Aurobindo Pharma – Milpharm Ltd).
- Generic
- Zopiclone
- Formulation
- Zopiclone 3.75mg tablets
-
Zopiclone
-
Zopiclone 3.75mg tablets
-
Zopiclone 3.75mg tablets (Medihealth (Northern) Ltd)
-
-